CynthiaE.HerzogMD

Pediatric Hematology & Oncology • Houston, TX

Professor of Pediatrics The University of Texas MD Anderson Cancer Center

Join to view full profile

Dr. Herzog is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Herzog's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 1988 - 1992
University of Texas Southwestern Medical CenterResidency, Pediatrics, 1986 - 1988
University of Texas Southwestern Medical CenterInternship, Pediatrics, 1985 - 1986
University of Texas Medical Branch School of MedicineClass of 1985

Certifications & Licensure

FL State Medical License 2021 - Present
OK State Medical License 2020 - 2026
TN State Medical License 2024 - 2026
WA State Medical License 2024 - 2026
AZ State Medical License 2024 - 2025
GA State Medical License 2024 - 2025
LA State Medical License 2024 - 2025
MS State Medical License 2024 - 2025
TX State Medical License 1987 - 2025
AL State Medical License 2024 - 2024
American Board of Pediatrics Pediatric Hematology-Oncology
Join now to see all

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies Start of enrollment: 2000 Jun 01
Completed
Phase 2
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma Start of enrollment: 2006 Jun 01
Completed
Phase 1, Phase 2
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Start of enrollment: 2009 Oct 30
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Start of enrollment: 2011 Feb 09
Completed
Phase 1, Phase 2
Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma Start of enrollment: 2011 Dec 01
Completed
Phase 2
Ph 1 Study of ADI PEG 20 in Pediatric Subjects Who Are Argininosuccinate Synthetase (ASS) Deficient Start of enrollment: 2011 Dec 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem ...
Irtiza N Sheikh, Destiny Uwaezuoke, Olayinka Okeleji, Andres Quesada, Cynthia E Herzog
Pediatric Blood & Cancer. 2024-12-19
The Impact of Surgical Margin in Wide Local Excision of Pediatric Melanoma - An Argument for a More Conservative Approach.
Anthony V Basta, Connor D Fritz, Yi-Ju Chiang, Neha Malik, Lily Koscielniak
Journal of Pediatric Surgery. 2024-09-10
Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries.
Alexander T Nelson, Anne K Harris, Dave Watson, Junne Kamihara, Kenneth S Chen
Gynecologic Oncology. 2024-07-01

Journal Articles

Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival
Alexander J Lazar, Joseph A Ludwig, Cynthia E Herzog, Raphael E Pollock, Clinical Cancer Research

Professional Memberships

American Society of Clinical Oncology - ASCO
Member